TIKOMED AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tikomed.com
Clinical Trials
8
Active:5
Completed:0
Trial Phases
2 Phases
Phase 1:4
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (57.1%)Phase 2
3 (42.9%)Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation
- First Posted Date
- 2019-03-08
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- TikoMed AB
- Target Recruit Count
- 7
- Registration Number
- NCT03867851
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
🇳🇴Oslo Universitetssykehus HF, Oslo, Norway
🇸🇪Sahlgrenska sjukhuset, Göteborg, Sweden
A Study to Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral Sclerosis
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- TikoMed AB
- Target Recruit Count
- 13
- Registration Number
- NCT03613571
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Gothenburg, Sweden
News
No news found